Literature DB >> 19653132

Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain.

Katsumichi Takeda1, Mai Muramatsu, Toshiyuki Chikuma, Takeshi Kato.   

Abstract

Neuropathic pain induced by sciatic nerve injury not only causes peripheral dysfunctions but also affects the cortical and subcortical regions of the brain. It is still unknown whether neuropathic pain could relate to behavioral and neurochemical alterations in the central nervous system. This paper deals with the effect of peripheral neuropathic pain on mechanical allodynia, neuropeptide levels, neuropeptide-degrading enzyme activities, and microglial cells in the brain regions of rats by applying chronic constriction injury, a partial sciatic nerve injury. We examined the possible protection effect on the allodynia and changes in levels of neuropeptides and microglial activation in chronic constriction injury of the rat brain by memantine. On 4 days after chronic constriction injury, the induction of mechanical allodynia was suppressed by memantine treatment. Reductions in the substance P in the hypothalamus and somatostatin in the periaqueductal gray of chronic constriction injury rat brain were reversed by memantine. This suggests the role of these neuropeptides in pain information processing in the brain. Immunohistochemical experiments revealed that the expression of CD11b, a marker protein of microglia, was increased in the hypothalamus and periaqueductal gray in the chronic constriction injury rat brain as compared with the controls, and memantine treatment could suppress the activation of microglia, suggesting the involvement of microglia in pain mechanism. The present behavioral, biochemical, and immunohistochemical studies demonstrated that peripheral neuropathic pain affects the neuropeptide levels and microglial activation in the brain regions, and these events described above may play an important role in neuropathic pain pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653132     DOI: 10.1007/s12031-009-9224-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  55 in total

1.  Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16.

Authors:  P Dahms; R Mentlein
Journal:  Eur J Biochem       Date:  1992-08-15

Review 2.  N-methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics.

Authors:  Dean G Brown; Johannes J Krupp
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

3.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

4.  Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.

Authors:  Takashi Saito; Nobuhisa Iwata; Satoshi Tsubuki; Yoshie Takaki; Jiro Takano; Shu-Ming Huang; Takahiro Suemoto; Makoto Higuchi; Takaomi C Saido
Journal:  Nat Med       Date:  2005-03-20       Impact factor: 53.440

Review 5.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

6.  Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids.

Authors:  X Y Hua; P Chen; M Marsala; T L Yaksh
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

7.  Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors.

Authors:  E M Davidson; S M Carlton
Journal:  Brain Res       Date:  1998-02-23       Impact factor: 3.252

8.  Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration.

Authors:  Annika Rosén; Yu-Xuan Zhang; Irene Lund; Thomas Lundeberg; Long-Chuan Yu
Journal:  Brain Res       Date:  2004-03-19       Impact factor: 3.252

9.  Spinal p38 MAP kinase is necessary for NMDA-induced spinal PGE(2) release and thermal hyperalgesia.

Authors:  Camilla I Svensson; Xiao-Ying Hua; Andrew A Protter; Henry C Powell; Tony L Yaksh
Journal:  Neuroreport       Date:  2003-06-11       Impact factor: 1.837

10.  NMDA antagonist neurotoxicity: mechanism and prevention.

Authors:  J W Olney; J Labruyere; G Wang; D F Wozniak; M T Price; M A Sesma
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

View more
  9 in total

1.  Spinal cord stimulation modulates cerebral function: an fMRI study.

Authors:  M Moens; S Sunaert; P Mariën; R Brouns; A De Smedt; S Droogmans; P Van Schuerbeek; R Peeters; J Poelaert; B Nuttin
Journal:  Neuroradiology       Date:  2012-09-02       Impact factor: 2.804

2.  Bilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain model.

Authors:  Ivana Hradilová Svízenská; Václav Brázda; Ilona Klusáková; Petr Dubový
Journal:  J Histochem Cytochem       Date:  2013-05-08       Impact factor: 2.479

3.  TNF-α Differentially Regulates Synaptic Plasticity in the Hippocampus and Spinal Cord by Microglia-Dependent Mechanisms after Peripheral Nerve Injury.

Authors:  Yong Liu; Li-Jun Zhou; Jun Wang; Dai Li; Wen-Jie Ren; Jiyun Peng; Xiao Wei; Ting Xu; Wen-Jun Xin; Rui-Ping Pang; Yong-Yong Li; Zhi-Hai Qin; Madhuvika Murugan; Mark P Mattson; Long-Jun Wu; Xian-Guo Liu
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

4.  Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus.

Authors:  Elodie Brison; Hélène Jacomy; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 5.  Inflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain.

Authors:  C Linnman; L Becerra; D Borsook
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-29       Impact factor: 4.147

6.  Evidence for a distinct neuro-immune signature in rats that develop behavioural disability after nerve injury.

Authors:  Paul J Austin; Annika M Berglund; Sherman Siu; Nathan T Fiore; Michelle B Gerke-Duncan; Suzanne L Ollerenshaw; Sarah-Jane Leigh; Priya A Kunjan; James W M Kang; Kevin A Keay
Journal:  J Neuroinflammation       Date:  2015-05-20       Impact factor: 8.322

7.  Memantine selectively prevented the induction of dynamic allodynia by blocking Kir2.1 channel and inhibiting the activation of microglia in spinal dorsal horn of mice in spared nerve injury model.

Authors:  Yangyang Chen; Yiqian Shi; Guoxiang Wang; Yimei Li; Longzhen Cheng; Yun Wang
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

8.  Effect of acetyl-L-carnitine on hypersensitivity in acute recurrent caerulein-induced pancreatitis and microglial activation along the brain's pain circuitry.

Authors:  Sabrina L McIlwrath; Marlene E Starr; Abigail E High; Hiroshi Saito; Karin N Westlund
Journal:  World J Gastroenterol       Date:  2021-03-07       Impact factor: 5.742

Review 9.  A Fatal Alliance between Microglia, Inflammasomes, and Central Pain.

Authors:  Stefanie Hoffmann; Cordian Beyer
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.